Immunomedics Inc
Change company Symbol lookup
Select an option...
IMMU Immunomedics Inc
RYT Invesco S&P 500® Equal Weight Technology ETF
VIEIX Vanguard Extended Market Index Fund Institutional Shares
ARCC Ares Capital Corp
EDIT Editas Medicine Inc
SMRT Stein Mart Inc
CBU Community Bank System Inc
BTA BlackRock Long-Term Municipal Advantage Trust
ARCI Appliance Recycling Centers of America Inc
PANXF Platinex Inc
Go

Health Care : Biotechnology | Small Cap BlendCompany profile

Immunomedics, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing monoclonal antibody-based products for the targeted treatment of cancer. Its technologies allow it to create humanized antibodies that can be used either alone in unlabeled or naked form, or conjugated with radioactive isotopes, chemotherapeutics, cytokines or toxins. It has a pipeline of six clinical-stage product candidates. Its portfolio of investigational products includes antibody-drug conjugates (ADCs) that are designed to deliver a payload of a chemotherapeutic directly to the tumor, while the managing overall toxic effects that are found with conventional administration of these chemotherapy agents. Its ADCs are sacituzumab govitecan (IMMU-132) and labetuzumab govitecan (IMMU-130). The Company also has a range of other product candidates that target solid tumors and hematologic malignancies, as well as other diseases, in various-stages of clinical and pre-clinical development.

Closing Price
$13.93
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
0

10-day average volume:
1,707,635
0
  • Prev Close
    13.93
  • Today's Open
    --
  • Day's Range
    --
  • Avg Vol (10-day)
    1.7M
  • Last (time)
    4:00p ET 08/21/19
  • Last (size)
    42.4K
  • 52-Wk Range
    11.55 - 26.99
    LowHigh
  • (09/04/18 - 01/18/19)
    20.61%
  • 67.3%
  • Market Cap
    2.7B
  • Shares Outstanding
    192.0M
  • -1.36
  • --
  • No dividend
  • Ex-dividend
    No dividend
  • 2.0
  • 89.59
  • (% of float 07/31/19)
    21.22

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.